Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Ca-A Cancer Journal for Clinicians is Scopus-indexed (Q1, CiteScore 649.8), WoS SCIE. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 0007-9235Verify ISSN ↗1542-4863Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 1 / 428 | 99th | Q1 |
| Hematology | 1 / 151 | 99th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 1950–present, best quartile Q1, CiteScore 649.8.
Ca-A Cancer Journal for Clinicians is Q1 in Oncology (rank 1 of 428) and Q1 in Hematology (rank 1 of 151), by CiteScore 2025.
Ca-A Cancer Journal for Clinicians is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 649.8, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 104.065, quartile Q1, with an H-index of 236.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,330 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Ca-A Cancer Journal for Clinicians is published by John Wiley and Sons Inc. Its print ISSN is 0007-9235 and its online ISSN is 1542-4863.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Ca-A Cancer Journal for Clinicians has an h-index of 270 and a 2-year mean of 224.07 citations per paper (OpenAlex). Its Scopus CiteScore is 649.8, quartile Q1. On 2-year citations it ranks #1 of 424 Scopus journals in Oncology.
Ca-A Cancer Journal for Clinicians published 80 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 77 research articles (2025–2026), authors are most often from United States (71%), China (5.8%) and United Kingdom (2.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.